Transdominant ΔTAp73 Isoforms Are Frequently Up-regulated in Ovarian Cancer. Evidence for Their Role as Epigenetic p53 Inhibitors <b> <i>in Vivo</i> </b>Nicole Concin, Ute M. Moll, Elizabeth Mueller-Holzner et al.|Cancer Research|2004Cited by 137
Alternative splicing of p53 and p73: the novel p53 splice variant p53δ is an independent prognostic marker in ovarian cancerGerda Hofstetter, Robert Zeillinger, Astrid Berger et al.|Oncogene|2010Cited by 81